NARSskin Night Treatment Recalled Due to Sudan IV Detection
Summary
The Health Sciences Authority (HSA) of Singapore has initiated a retail-level recall for all batches of NARSskin light reflecting restorative night treatment. The product was found to contain Sudan IV, a substance not permitted in cosmetic products, during a quality surveillance program. Local company Shiseido Singapore Co. (Pte) Limited is instructed to stop supplying the product and return existing stocks.
What changed
The Health Sciences Authority (HSA) of Singapore has issued a recall for all batches of NARSskin light reflecting restorative night treatment due to the detection of Sudan IV. This substance is prohibited in cosmetic products, and its presence was identified during HSA's routine product quality surveillance. The recall is classified as Class 2, indicating it would not likely cause serious adverse health outcomes, and is at the retail level, requiring suppliers to cease distribution and return stock to Shiseido Singapore Co. (Pte) Limited.
Retail and wholesale suppliers must immediately stop supplying all batches of the affected product and return any remaining inventory to the local company. This action ensures that cosmetic products available in Singapore adhere to stringent regulatory standards for quality and safety. While this specific recall is classified as Class 2, it underscores the importance of rigorous quality control for all cosmetic products distributed within Singapore.
What to do next
- Stop supplying all batches of NARSskin light reflecting restorative night treatment.
- Return remaining stocks of the product to Shiseido Singapore Co. (Pte) Limited.
Source document (simplified)
NARSskin light reflecting restorative night treatment (CCPN2126133)
Retail-level recall of all batches of NARSskin light reflecting restorative night treatment due to Sudan IV detected
| Date of Recall: | 20 March 2026 |
| Product: | NARSskin light reflecting restorative night treatment |
| Product Category: | Cosmetic Product |
| Batch No.: | All batches |
| Class of Recall: | 2 |
| Level of Recall: | Retail |
| Local Company: | Shiseido Singapore Co. (Pte) Limited |
| Description of Issue: | The product was tested under HSA’s product quality surveillance programme and detected to contain Sudan IV. |
| Recall Instructions: | Retail and wholesale suppliers:
Stop supplying all batches of the product and return the remaining stocks to the company. |
Note:
The Health Sciences Authority (HSA) publishes information regarding recalls of health products supplied in Singapore. These product recalls may be conducted on a company’s own initiative or upon HSA’s request to remove products where there are issues with quality, safety or efficacy.
When a recall is initiated, it does not necessarily imply that a product is considered unsafe or is inefficacious. A recall can also be initiated to remove products with quality defects that does not impact safety or efficacy from the market so as to ensure that products registered in Singapore continue to meet the stringent regulatory standards stipulated by HSA.
Not all recalls will lead to press releases. However, when a recall involves a product that has been widely distributed or a product that poses a serious health risk, HSA will issue a press release to inform members of public.
Class of recall
A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.
- Class 1: For recalls of products with issues that can potentially **** cause serious adverse health outcomes or death.
- Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.
Level of recall
The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.
- Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.
- Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.
- Wholesale level: Affected product or batch(es) recalled from wholesale suppliers. Healthcare professional, Industry member, Cosmetic products Published:
20 Mar 2026
Product Recalls
23 Mar 2026
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when HSA Singapore Announcements publishes new changes.